Editas Medicine, Inc. Business Finance Contracts & Agreements

12 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Inducement Restricted Stock Unit Award Agreement for the Registrants executive officers
Stock Agreements
Editas Medicine, Inc.
Biotechnology
DE
2024
Form of Inducement Stock Option Agreement for the Registrants executive officers
Stock Agreements
Editas Medicine, Inc.
Biotechnology
DE
2024
Underwriting Agreement, June 14, 2023, by and among the Company, J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group, L.L.C
Underwriting Agreements
Editas Medicine, Inc.
Biotechnology
NY
2023
Common Stock Sales Agreement, dated as of May 14, 2021, by and between the Company and Cowen and Company, LLC
Stock Agreements
Editas Medicine, Inc.
Biotechnology
NY
2021
Underwriting Agreement, dated January 20, 2021, by and among the Company, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC
Underwriting Agreements
Editas Medicine, Inc.
Biotechnology
NY
2021
Underwriting Agreement, dated June 23, 2020, by and between the Company and the Underwriter
Underwriting Agreements
Editas Medicine, Inc.
Biotechnology
NY
2020
Common Stock Sales Agreement, dated as of May 15, 2020, by and between the Company and Cowen
Stock Agreements
Editas Medicine, Inc.
Biotechnology
NY
2020
Form of Inducement Restricted Stock Unit Award Agreement for the Registrants executive officers
Stock Agreements
Editas Medicine, Inc.
Biotechnology
DE
2020
Form of Inducement Stock Option Agreement for the Registrants executive officers
Stock Agreements
Editas Medicine, Inc.
Biotechnology
DE
2020
Underwriting Agreement, dated December 5, 2017, by and among Editas Medicine, Inc. and Morgan Stanley & Co. LLC
Underwriting Agreements
Editas Medicine, Inc.
Biotechnology
NY
2017
4,000,000 Shares EDITAS MEDICINE, INC. COMMON STOCK, $0.0001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreements
Editas Medicine, Inc.
Biotechnology
NY
2017
[ ] Shares EDITAS MEDICINE, INC. COMMON STOCK, $0.0001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreements
Editas Medicine, Inc.
Biotechnology
NY
2016